Dr. Sina Mirbagheri, MD

Dr. Mirbagheri practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Mirbagheri's NPI, 1801425673, was assigned on April 3, 2020. Dr. Mirbagheri graduated from Tehran University of Medical Sciences School of Medicine in 2017. Dr. Mirbagheri holds California license A182127.

Dr. Mirbagheri's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Mirbagheri's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Mirbagheri is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirbagheri practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mirbagheri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mirbagheri is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mirbagheri is licensed in California.

CMS data shows 322 Medicare services from Dr. Mirbagheri across 4 procedure codes in 2024, for 158 Medicare patients. Medicare paid $32,236 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 158 Medicare patients who saw Dr. Mirbagheri in 2024. The largest group is 75 to 84, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 3.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirbagheri's median patient age at 59, with 49% women.

In 2024, Dr. Mirbagheri wrote 48 Medicare Part D claims for 24 patients. 83% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $372 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Mirbagheri for performance year 2024, reported as part of a group. Dr. Mirbagheri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Mirbagheri from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Mitsubishi Tanabe Pharma America, Inc. paid the most, $28.

Dr. Mirbagheri graduated from Tehran University of Medical Sciences School of Medicine in 2017.

Dr. Mirbagheri is in network with 2 carriers, including Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.